SALIX PHARMACEUTICALS LTD Financing Cash Flow
SALIX PHARMACEUTICALS LTD reported Financing Cash Flow of $1.78 billion for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2015-03-02
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) financing activities for the quarter ending 2013-12-31 was $2.19M.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) financing activities for the quarter ending 2013-09-30 was -$8.77M, a 249.26% decline year-over-year.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) financing activities for the quarter ending 2013-06-30 was $4.35M, a 12.50% increase year-over-year.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) financing activities for the quarter ending 2013-03-31 was -$360.00K, a 100.09% decline year-over-year.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) financing activities for fiscal 2014 was $1.78B.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) financing activities for fiscal 2013 was -$2.59M, a 100.67% decline from fiscal 2012.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) financing activities for fiscal 2012 was $385.62M, a 769.18% increase from fiscal 2011.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) financing activities for fiscal 2011 was $44.37M, a 84.73% decline from fiscal 2010.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2014-12-31 | $1.78B 10-K · filed 2015-03-02 | |||
| 2013-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$6.58M derived: sum of 2 quarters · filed 2015-03-02 | -$2.23M derived: sum of 3 quarters · filed 2015-03-02 | -$2.59M 10-K · filed 2015-03-02 |
| 2013-09-30 | -$8.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$4.42M derived: sum of 2 quarters · filed 2013-11-08 | -$4.78M 10-Q · filed 2013-11-08 | -$20.84M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $4.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $3.99M 10-Q · filed 2013-08-09 | -$12.08M derived: sum of 3 quarters · filed 2015-03-02 | -$6.20M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | -$360.00K 10-Q · filed 2013-05-10 | -$16.42M derived: sum of 2 quarters · filed 2015-03-02 | -$10.55M derived: sum of 3 quarters · filed 2015-03-02 | -$6.69M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | -$16.06M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$10.19M derived: sum of 2 quarters · filed 2015-03-02 | -$6.33M derived: sum of 3 quarters · filed 2015-03-02 | $385.62M 10-K · filed 2015-03-02 |
| 2012-09-30 | $5.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $9.74M derived: sum of 2 quarters · filed 2013-11-08 | $401.69M 10-Q · filed 2013-11-08 | $433.52M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-06-30 | $3.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $395.81M 10-Q · filed 2013-08-09 | $427.65M derived: sum of 3 quarters · filed 2015-03-02 | $430.32M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-03-31 | $391.95M 10-Q · filed 2013-05-10 | $423.78M derived: sum of 2 quarters · filed 2015-03-02 | $426.46M derived: sum of 3 quarters · filed 2015-03-02 | $433.57M derived: sum of 4 quarters · filed 2015-03-02 |
| 2011-12-31 | $31.84M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $34.51M derived: sum of 2 quarters · filed 2015-03-02 | $41.62M derived: sum of 3 quarters · filed 2015-03-02 | $44.37M 10-K · filed 2015-03-02 |
| 2011-09-30 | $2.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $9.79M derived: sum of 2 quarters · filed 2012-11-08 | $12.53M 10-Q · filed 2012-11-08 | $16.89M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $7.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $9.86M 10-Q · filed 2012-08-09 | $14.21M derived: sum of 3 quarters · filed 2013-03-01 | $14.57M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $2.74M 10-Q · filed 2012-05-08 | $7.10M derived: sum of 2 quarters · filed 2013-03-01 | $7.45M derived: sum of 3 quarters · filed 2013-03-01 | $286.99M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $4.36M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $4.71M derived: sum of 2 quarters · filed 2013-03-01 | $284.25M derived: sum of 3 quarters · filed 2013-03-01 | $290.57M 10-K · filed 2013-03-01 |
| 2010-09-30 | $356.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $279.90M derived: sum of 2 quarters · filed 2011-11-09 | $286.22M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $279.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $285.86M 10-Q · filed 2011-08-09 | ||
| 2010-03-31 | $6.32M 10-Q · filed 2011-05-10 | |||
| 2009-12-31 | $140.82M 10-K · filed 2012-02-28 |